What laboratory tests are indicated for a patient presenting with diarrhea and abdominal pain?

Laboratory Testing for Diarrhea and Abdominal Pain

Test all patients with diarrhea and abdominal pain for celiac disease (IgA tissue transglutaminase plus IgA level), Giardia, and use fecal calprotectin or fecal lactoferrin to screen for inflammatory bowel disease; if fever or bloody stools are present, add stool culture for Salmonella, Shigella, Campylobacter, and Shiga toxin testing. 1, 2, 3

Acute vs. Chronic Diarrhea Context

The laboratory approach differs based on duration:

• Acute diarrhea (< 4 weeks): Focus on infectious etiologies, especially when fever, bloody stools, or severe cramping are present 2, 4
• Chronic diarrhea (≥ 4 weeks): Broader differential including celiac disease, inflammatory bowel disease, bile acid diarrhea, and functional disorders 1, 3

Essential First-Line Tests (All Patients)

Celiac Disease Screening

• Perform IgA tissue transglutaminase (IgA-tTG) testing in all patients with chronic diarrhea 1, 3
• Simultaneously measure total IgA level to detect IgA deficiency 1, 3
• If IgA-deficient, use IgG-tTG or IgG deamidated gliadin peptides instead 1, 3
• IgA-tTG demonstrates >90% sensitivity and specificity at thresholds of 7–15 AU/mL 1, 3
• This is a strong recommendation with moderate-quality evidence 1

Inflammatory Bowel Disease Screening

• Use fecal calprotectin (≥50 µg/g cutoff) OR fecal lactoferrin (4.0–7.25 mg/g) as first-line IBD screen 1, 3
• Fecal calprotectin at 50 µg/g has 81% sensitivity and 87% specificity for IBD 3
• Do NOT use ESR or CRP for IBD screening—these have limited diagnostic utility (≈73% sensitivity, ≈78% specificity) 1, 3
• If fecal inflammatory markers are elevated, proceed to colonoscopy with biopsies 3

Infectious Etiology

• Test all patients for Giardia lamblia using stool ELISA (92% sensitivity, 98% specificity) 1, 3, 4
• This is a strong recommendation with high-quality evidence 1

Additional Testing Based on Clinical Features

Fever or Bloody Diarrhea Present

• Stool culture for Salmonella, Shigella, Campylobacter, and Yersinia 2, 4
• Shiga toxin testing (or genes encoding toxins) to detect STEC, including E. coli O157:H7 2
• Use sorbitol-MacConkey agar or chromogenic agar for O157:H7; Shiga toxin detection needed for non-O157 STEC 2
• Clostridioides difficile testing if recent antibiotic use or healthcare exposure 2, 4
  • Use glutamate dehydrogenase (GDH) test or PCR for high sensitivity, but confirm with toxin A/B enzyme immunoassay to distinguish infection from colonization 4

Blood Cultures Indicated When:

• Infants <3 months of age 2
• Signs of septicemia or enteric fever suspected 2
• Immunocompromised patients 2
• Travel to enteric fever-endemic areas with febrile illness 2

Specific Epidemiologic Exposures

• Vibrio species testing: Large-volume rice-water stools, exposure to brackish water, raw shellfish consumption, or travel to cholera-endemic regions within 3 days 2
• Yersinia enterocolitica: Right lower quadrant pain mimicking appendicitis (especially school-aged children) or exposure to undercooked pork 2
• Ova and parasites: ONLY if recent travel to or immigration from high-risk areas 1, 3
  • Do NOT routinely test for ova and parasites in patients without travel history 1

Chronic Diarrhea with Normal Initial Tests

Bile Acid Diarrhea Evaluation

• Consider testing for bile acid diarrhea in patients with watery diarrhea 1, 3
• U.S. testing options: 48-hour stool bile acid collection or serum FGF-19 level 1, 3
• If specialized testing unavailable, empiric trial of bile acid binders (cholestyramine, colesevelam) is reasonable 1, 3
• This is a conditional recommendation with low-quality evidence 1

Age-Based Colonoscopy

• Perform colonoscopy in all patients >50 years due to increased colorectal cancer risk 3
• For patients <50 years, colonoscopy indicated when alarm features present: weight loss, rectal bleeding, anemia, or family history of IBD/cancer 3
• Consider microscopic colitis in patients >60 years with watery diarrhea (prevalence ≈10% in chronic watery diarrhea cohorts) 3

Tests NOT Recommended

• IBS-specific serologic assays (anti-CdtB, anti-vinculin antibodies): Low diagnostic accuracy with sensitivity only 20–40% 3
• ESR or CRP for IBD screening: Inadequate sensitivity and specificity 1, 3
• Routine ova and parasite examination: Unless travel/immigration from endemic areas 1, 3

Common Diagnostic Pitfalls

• Do not rely solely on CBC, CRP, and basic metabolic panel—these have low diagnostic yield for distinguishing IBS-D from organic disease 3, 5
• Do not omit celiac testing even without classic extraintestinal symptoms—diarrhea-predominant celiac disease is common 3
• Borderline fecal calprotectin values just above 50 µg/g require clinical judgment; consider repeat testing or colonoscopy based on symptom severity 3
• Avoid prescribing antibiotics for C. difficile based on PCR alone—confirm with toxin assay to avoid treating colonization 3
• Weight loss, nocturnal diarrhea, and absence of tenesmus suggest organic rather than functional cause 5
• Laboratory abnormalities (elevated ESR, anemia, hypokalemia, low albumin) are found in 62% of organic diarrhea but only 3% of functional disease 5

Algorithmic Summary

1. All patients: IgA-tTG (plus IgA level), fecal calprotectin or lactoferrin, stool Giardia ELISA 1, 3
2. If fever or bloody stools: Add stool culture (Salmonella, Shigella, Campylobacter, Yersinia), Shiga toxin testing, consider C. difficile testing 2, 4
3. If fecal inflammatory markers elevated: Colonoscopy with biopsies 3
4. If age >50 years or alarm features: Colonoscopy regardless of fecal markers 3
5. If initial tests negative: Evaluate for bile acid diarrhea or empiric trial of bile acid binders 1, 3
6. IBS-D diagnosis: Confirmed when above investigations negative and Rome criteria met 3